サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1119341

世界の細胞毒性薬市場：考察と予測 (2028年まで)

Global Cytotoxic Drug Market Insights and Forecast to 2028
出版日: | 発行: QYResearch | ページ情報: 英文 95 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
世界の細胞毒性薬市場：考察と予測 (2028年まで)
出版日: 2022年08月26日
発行: QYResearch
ページ情報: 英文 95 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、細胞毒性薬 (Cytotoxic Drug) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析：タイプ別
    • 世界の細胞毒性薬の市場規模成長率：タイプ別, 2017 VS 2021 VS 2028
    • Injection
    • Solid Oral Dose Forms
    • Others
  • 市場：アプリケーション別
    • 世界の細胞毒性薬の市場規模成長率：アプリケーション別, 2017 VS 2021 VS 2028
    • Breast Cancer
    • Blood Cancer
    • Prostate Cancer
    • Respiratory/Lung Cancer
    • Other
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界の細胞毒性薬の市場展望 (2017-2028)
  • 細胞毒性薬の市場成長トレンド：地域別
    • 細胞毒性薬 市場規模：地域別: 2017 VS 2021 VS 2028
    • 細胞毒性薬の市場規模実績：地域別 (2017-2022)
    • 細胞毒性薬の市場規模予測：地域別 (2023-2028)
  • 細胞毒性薬 市場動向
    • 細胞毒性薬 業界動向
    • 細胞毒性薬 市場の促進要因
    • 細胞毒性薬 市場の課題
    • 細胞毒性薬 市場の抑制要因

第3章 競合情勢：主要企業別

  • 世界の細胞毒性薬の上位企業：収益別
    • 世界の細胞毒性薬の上位企業：収益別 (2017-2022)
    • 世界の細胞毒性薬の収益シェア：企業別 (2017-2022)
  • 世界の細胞毒性薬の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 企業ランキング：細胞毒性薬の収益
  • 世界の細胞毒性薬 市場集中度
    • 世界の細胞毒性薬 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業： 細胞毒性薬の収益 2021
  • 細胞毒性薬の主要企業の本社および事業エリア
  • 主要企業 細胞毒性薬の製品ソリューションおよびサービス
  • 市場参入時期： 細胞毒性薬 市場
  • M&A, 拡張計画

第4章 細胞毒性薬 内訳データ：タイプ別

  • 世界の細胞毒性薬の市場規模実績：タイプ別 (2017-2022)
  • 世界の細胞毒性薬の市場規模予測：タイプ別 (2023-2028)

第5章 細胞毒性薬 内訳データ：アプリケーション別

  • 世界の細胞毒性薬の市場規模実績：アプリケーション別 (2017-2022)
  • 世界の細胞毒性薬の市場規模予測：アプリケーション別 (2023-2028)

第6章 北米

  • 北米の細胞毒性薬 市場規模 (2017-2028)
  • 北米の細胞毒性薬 市場規模：タイプ別
    • 北米の細胞毒性薬 市場規模：タイプ別 (2017-2022)
    • 北米の細胞毒性薬 市場規模：タイプ別 (2023-2028)
    • 北米の細胞毒性薬の市場シェア：タイプ別 (2017-2028)
  • 北米の細胞毒性薬 市場規模：アプリケーション別
    • 北米の細胞毒性薬 市場規模：アプリケーション別 (2017-2022)
    • 北米の細胞毒性薬 市場規模：アプリケーション別 (2023-2028)
    • 北米の細胞毒性薬の市場シェア：アプリケーション別 (2017-2028)
  • 北米の細胞毒性薬 市場規模：国別
    • 北米の細胞毒性薬 市場規模：国別 (2017-2022)
    • 北米の細胞毒性薬 市場規模：国別 (2023-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の細胞毒性薬 市場規模 (2017-2028)
  • 欧州の細胞毒性薬 市場規模：タイプ別
    • 欧州の細胞毒性薬 市場規模：タイプ別 (2017-2022)
    • 欧州の細胞毒性薬 市場規模：タイプ別 (2023-2028)
    • 欧州の細胞毒性薬の市場シェア：タイプ別 (2017-2028)
  • 欧州の細胞毒性薬 市場規模：アプリケーション別
    • 欧州の細胞毒性薬 市場規模：アプリケーション別 (2017-2022)
    • 欧州の細胞毒性薬 市場規模：アプリケーション別 (2023-2028)
    • 欧州の細胞毒性薬の市場シェア：アプリケーション別 (2017-2028)
  • 欧州の細胞毒性薬 市場規模：国別
    • 欧州の細胞毒性薬 市場規模：国別 (2017-2022)
    • 欧州の細胞毒性薬 市場規模：国別 (2023-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 アジア太平洋地域

  • アジア太平洋地域 細胞毒性薬 市場規模 (2017-2028)
  • アジア太平洋地域 細胞毒性薬 市場規模：タイプ別
    • アジア太平洋地域 細胞毒性薬 市場規模：タイプ別 (2017-2022)
    • アジア太平洋地域 細胞毒性薬 市場規模：タイプ別 (2023-2028)
    • アジア太平洋地域 細胞毒性薬の市場シェア：タイプ別 (2017-2028)
  • アジア太平洋地域 細胞毒性薬 市場規模：アプリケーション別
    • アジア太平洋地域 細胞毒性薬 市場規模：アプリケーション別 (2017-2022)
    • アジア太平洋地域 細胞毒性薬 市場規模：アプリケーション別 (2023-2028)
    • アジア太平洋地域 細胞毒性薬の市場シェア：アプリケーション別 (2017-2028)
  • アジア太平洋地域 細胞毒性薬 市場規模：地域別
    • アジア太平洋地域 細胞毒性薬 市場規模：地域別 (2017-2022)
    • アジア太平洋地域 細胞毒性薬 市場規模：地域別 (2023-2028)
    • 中国
    • 日本
    • 韓国
    • 東南アジア
    • インド
    • オーストラリア

第9章 ラテンアメリカ

  • ラテンアメリカの細胞毒性薬 市場規模 (2017-2028)
  • ラテンアメリカの細胞毒性薬 市場規模：タイプ別
    • ラテンアメリカの細胞毒性薬 市場規模：タイプ別 (2017-2022)
    • ラテンアメリカの細胞毒性薬 市場規模：タイプ別 (2023-2028)
    • ラテンアメリカの細胞毒性薬の市場シェア：タイプ別 (2017-2028)
  • ラテンアメリカの細胞毒性薬 市場規模：アプリケーション別
    • ラテンアメリカの細胞毒性薬 市場規模：アプリケーション別 (2017-2022)
    • ラテンアメリカの細胞毒性薬 市場規模：アプリケーション別 (2023-2028)
    • ラテンアメリカの細胞毒性薬の市場シェア：アプリケーション別 (2017-2028)
  • ラテンアメリカの細胞毒性薬 市場規模：国別
    • ラテンアメリカの細胞毒性薬 市場規模：国別 (2017-2022)
    • ラテンアメリカの細胞毒性薬 市場規模：国別 (2023-2028)
    • メキシコ
    • ブラジル

第10章 中東・アフリカ

  • 中東・アフリカの細胞毒性薬 市場規模 (2017-2028)
  • 中東・アフリカの細胞毒性薬 市場規模：タイプ別
    • 中東・アフリカの細胞毒性薬 市場規模：タイプ別 (2017-2022)
    • 中東・アフリカの細胞毒性薬 市場規模：タイプ別 (2023-2028)
    • 中東・アフリカの細胞毒性薬の市場シェア：タイプ別 (2017-2028)
  • 中東・アフリカの細胞毒性薬 市場規模：アプリケーション別
    • 中東・アフリカの細胞毒性薬 市場規模：アプリケーション別 (2017-2022)
    • 中東・アフリカの細胞毒性薬 市場規模：アプリケーション別 (2023-2028)
    • 中東・アフリカの細胞毒性薬の市場シェア：アプリケーション別 (2017-2028)
  • 中東・アフリカの細胞毒性薬 市場規模：国別
    • 中東・アフリカの細胞毒性薬 市場規模：国別 (2017-2022)
    • 中東・アフリカの細胞毒性薬 市場規模：国別 (2023-2028)
    • トルコ
    • サウジアラビア
    • UAE

第11章 主要企業のプロファイル

  • Roche
  • Eli Lilly
  • Celgene
  • Sanofi
  • eisai
  • Sumitomo Dainippon Pharma
  • Merck
  • Seattle Genetics
  • Takeda
  • Haosoh Pharma
  • Novartis
  • AstraZeneca
  • Jazz Pharma
  • Spectrum Pharma

第12章 アナリストによる分析/結論

第13章 付録

図表
  • Table 1. Global Cytotoxic Drug Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Injection
  • Table 3. Key Players of Solid Oral Dose Forms
  • Table 4. Key Players of Others
  • Table 5. Global Cytotoxic Drug Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 6. Global Cytotoxic Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 7. Global Cytotoxic Drug Market Size by Region (2017-2022) & (US$ Million)
  • Table 8. Global Cytotoxic Drug Market Share by Region (2017-2022)
  • Table 9. Global Cytotoxic Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 10. Global Cytotoxic Drug Market Share by Region (2023-2028)
  • Table 11. Cytotoxic Drug Market Trends
  • Table 12. Cytotoxic Drug Market Drivers
  • Table 13. Cytotoxic Drug Market Challenges
  • Table 14. Cytotoxic Drug Market Restraints
  • Table 15. Global Cytotoxic Drug Revenue by Players (2017-2022) & (US$ Million)
  • Table 16. Global Cytotoxic Drug Revenue Share by Players (2017-2022)
  • Table 17. Global Top Cytotoxic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cytotoxic Drug as of 2021)
  • Table 18. Ranking of Global Top Cytotoxic Drug Companies by Revenue (US$ Million) in 2021
  • Table 19. Global 5 Largest Players Market Share by Cytotoxic Drug Revenue (CR5 and HHI) & (2017-2022)
  • Table 20. Key Players Headquarters and Area Served
  • Table 21. Key Players Cytotoxic Drug Product Solution and Service
  • Table 22. Date of Enter into Cytotoxic Drug Market
  • Table 23. Mergers & Acquisitions, Expansion Plans
  • Table 24. Global Cytotoxic Drug Market Size by Type (2017-2022) & (US$ Million)
  • Table 25. Global Cytotoxic Drug Revenue Market Share by Type (2017-2022)
  • Table 26. Global Cytotoxic Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 27. Global Cytotoxic Drug Revenue Market Share by Type (2023-2028)
  • Table 28. Global Cytotoxic Drug Market Size by Application (2017-2022) & (US$ Million)
  • Table 29. Global Cytotoxic Drug Revenue Share by Application (2017-2022)
  • Table 30. Global Cytotoxic Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 31. Global Cytotoxic Drug Revenue Share by Application (2023-2028)
  • Table 32. North America Cytotoxic Drug Market Size by Type (2017-2022) & (US$ Million)
  • Table 33. North America Cytotoxic Drug Market Size by Type (2023-2028) & (US$ Million)
  • Table 34. North America Cytotoxic Drug Market Size by Application (2017-2022) & (US$ Million)
  • Table 35. North America Cytotoxic Drug Market Size by Application (2023-2028) & (US$ Million)
  • Table 36. North America Cytotoxic Drug Market Size by Country (2017-2022) & (US$ Million)
  • Table 37. North America Cytotoxic Drug Market Size by Country (2023-2028) & (US$ Million)
  • Table 38. Europe Cytotoxic Drug Market Size by Type (2017-2022) & (US$ Million)
  • Table 39. Europe Cytotoxic Drug Market Size by Type (2023-2028) & (US$ Million)
  • Table 40. Europe Cytotoxic Drug Market Size by Application (2017-2022) & (US$ Million)
  • Table 41. Europe Cytotoxic Drug Market Size by Application (2023-2028) & (US$ Million)
  • Table 42. Europe Cytotoxic Drug Market Size by Country (2017-2022) & (US$ Million)
  • Table 43. Europe Cytotoxic Drug Market Size by Country (2023-2028) & (US$ Million)
  • Table 44. Asia Pacific Cytotoxic Drug Market Size by Type (2017-2022) & (US$ Million)
  • Table 45. Asia Pacific Cytotoxic Drug Market Size by Type (2023-2028) & (US$ Million)
  • Table 46. Asia Pacific Cytotoxic Drug Market Size by Application (2017-2022) & (US$ Million)
  • Table 47. Asia Pacific Cytotoxic Drug Market Size by Application (2023-2028) & (US$ Million)
  • Table 48. Asia Pacific Cytotoxic Drug Market Size by Region (2017-2022) & (US$ Million)
  • Table 49. Asia Pacific Cytotoxic Drug Market Size by Region (2023-2028) & (US$ Million)
  • Table 50. Latin America Cytotoxic Drug Market Size by Type (2017-2022) & (US$ Million)
  • Table 51. Latin America Cytotoxic Drug Market Size by Type (2023-2028) & (US$ Million)
  • Table 52. Latin America Cytotoxic Drug Market Size by Application (2017-2022) & (US$ Million)
  • Table 53. Latin America Cytotoxic Drug Market Size by Application (2023-2028) & (US$ Million)
  • Table 54. Latin America Cytotoxic Drug Market Size by Country (2017-2022) & (US$ Million)
  • Table 55. Latin America Cytotoxic Drug Market Size by Country (2023-2028) & (US$ Million)
  • Table 56. Middle East and Africa Cytotoxic Drug Market Size by Type (2017-2022) & (US$ Million)
  • Table 57. Middle East and Africa Cytotoxic Drug Market Size by Type (2023-2028) & (US$ Million)
  • Table 58. Middle East and Africa Cytotoxic Drug Market Size by Application (2017-2022) & (US$ Million)
  • Table 59. Middle East and Africa Cytotoxic Drug Market Size by Application (2023-2028) & (US$ Million)
  • Table 60. Middle East and Africa Cytotoxic Drug Market Size by Country (2017-2022) & (US$ Million)
  • Table 61. Middle East and Africa Cytotoxic Drug Market Size by Country (2023-2028) & (US$ Million)
  • Table 62. Roche Company Details
  • Table 63. Roche Business Overview
  • Table 64. Roche Cytotoxic Drug Product
  • Table 65. Roche Revenue in Cytotoxic Drug Business (2017-2022) & (US$ Million)
  • Table 66. Roche Recent Developments
  • Table 67. Eli Lilly Company Details
  • Table 68. Eli Lilly Business Overview
  • Table 69. Eli Lilly Cytotoxic Drug Product
  • Table 70. Eli Lilly Revenue in Cytotoxic Drug Business (2017-2022) & (US$ Million)
  • Table 71. Eli Lilly Recent Developments
  • Table 72. Celgene Company Details
  • Table 73. Celgene Business Overview
  • Table 74. Celgene Cytotoxic Drug Product
  • Table 75. Celgene Revenue in Cytotoxic Drug Business (2017-2022) & (US$ Million)
  • Table 76. Celgene Recent Developments
  • Table 77. Sanofi Company Details
  • Table 78. Sanofi Business Overview
  • Table 79. Sanofi Cytotoxic Drug Product
  • Table 80. Sanofi Revenue in Cytotoxic Drug Business (2017-2022) & (US$ Million)
  • Table 81. Sanofi Recent Developments
  • Table 82. eisai Company Details
  • Table 83. eisai Business Overview
  • Table 84. eisai Cytotoxic Drug Product
  • Table 85. eisai Revenue in Cytotoxic Drug Business (2017-2022) & (US$ Million)
  • Table 86. eisai Recent Developments
  • Table 87. Sumitomo Dainippon Pharma Company Details
  • Table 88. Sumitomo Dainippon Pharma Business Overview
  • Table 89. Sumitomo Dainippon Pharma Cytotoxic Drug Product
  • Table 90. Sumitomo Dainippon Pharma Revenue in Cytotoxic Drug Business (2017-2022) & (US$ Million)
  • Table 91. Sumitomo Dainippon Pharma Recent Developments
  • Table 92. Merck Company Details
  • Table 93. Merck Business Overview
  • Table 94. Merck Cytotoxic Drug Product
  • Table 95. Merck Revenue in Cytotoxic Drug Business (2017-2022) & (US$ Million)
  • Table 96. Merck Recent Developments
  • Table 97. Seattle Genetics Company Details
  • Table 98. Seattle Genetics Business Overview
  • Table 99. Seattle Genetics Cytotoxic Drug Product
  • Table 100. Seattle Genetics Revenue in Cytotoxic Drug Business (2017-2022) & (US$ Million)
  • Table 101. Seattle Genetics Recent Developments
  • Table 102. Takeda Company Details
  • Table 103. Takeda Business Overview
  • Table 104. Takeda Cytotoxic Drug Product
  • Table 105. Takeda Revenue in Cytotoxic Drug Business (2017-2022) & (US$ Million)
  • Table 106. Takeda Recent Developments
  • Table 107. Haosoh Pharma Company Details
  • Table 108. Haosoh Pharma Business Overview
  • Table 109. Haosoh Pharma Cytotoxic Drug Product
  • Table 110. Haosoh Pharma Revenue in Cytotoxic Drug Business (2017-2022) & (US$ Million)
  • Table 111. Haosoh Pharma Recent Developments
  • Table 112. Novartis Company Details
  • Table 113. Novartis Business Overview
  • Table 114. Novartis Cytotoxic Drug Product
  • Table 115. Novartis Revenue in Cytotoxic Drug Business (2017-2022) & (US$ Million)
  • Table 116. Novartis Recent Developments
  • Table 117. AstraZeneca Company Details
  • Table 118. AstraZeneca Business Overview
  • Table 119. AstraZeneca Cytotoxic Drug Product
  • Table 120. AstraZeneca Revenue in Cytotoxic Drug Business (2017-2022) & (US$ Million)
  • Table 121. AstraZeneca Recent Developments
  • Table 122. Jazz Pharma Company Details
  • Table 123. Jazz Pharma Business Overview
  • Table 124. Jazz Pharma Cytotoxic Drug Product
  • Table 125. Jazz Pharma Revenue in Cytotoxic Drug Business (2017-2022) & (US$ Million)
  • Table 126. Jazz Pharma Recent Developments
  • Table 127. Spectrum Pharma Company Details
  • Table 128. Spectrum Pharma Business Overview
  • Table 129. Spectrum Pharma Cytotoxic Drug Product
  • Table 130. Spectrum Pharma Revenue in Cytotoxic Drug Business (2017-2022) & (US$ Million)
  • Table 131. Spectrum Pharma Recent Developments
  • Table 132. Research Programs/Design for This Report
  • Table 133. Key Data Information from Secondary Sources
  • Table 134. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Cytotoxic Drug Market Share by Type: 2021 VS 2028
  • Figure 2. Injection Features
  • Figure 3. Solid Oral Dose Forms Features
  • Figure 4. Others Features
  • Figure 5. Global Cytotoxic Drug Market Share by Application: 2021 VS 2028
  • Figure 6. Breast Cancer Case Studies
  • Figure 7. Blood Cancer Case Studies
  • Figure 8. Prostate Cancer Case Studies
  • Figure 9. Respiratory/Lung Cancer Case Studies
  • Figure 10. Other Case Studies
  • Figure 11. Cytotoxic Drug Report Years Considered
  • Figure 12. Global Cytotoxic Drug Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 13. Global Cytotoxic Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 14. Global Cytotoxic Drug Market Share by Region: 2021 VS 2028
  • Figure 15. Global Cytotoxic Drug Market Share by Players in 2021
  • Figure 16. Global Top Cytotoxic Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cytotoxic Drug as of 2021)
  • Figure 17. The Top 10 and 5 Players Market Share by Cytotoxic Drug Revenue in 2021
  • Figure 18. North America Cytotoxic Drug Market Size YoY (2017-2028) & (US$ Million)
  • Figure 19. North America Cytotoxic Drug Market Size Market Share by Type (2017-2028)
  • Figure 20. North America Cytotoxic Drug Market Size Market Share by Application (2017-2028)
  • Figure 21. North America Cytotoxic Drug Market Size Share by Country (2017-2028)
  • Figure 22. United States Cytotoxic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 23. Canada Cytotoxic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 24. Europe Cytotoxic Drug Market Size YoY (2017-2028) & (US$ Million)
  • Figure 25. Europe Cytotoxic Drug Market Size Market Share by Type (2017-2028)
  • Figure 26. Europe Cytotoxic Drug Market Size Market Share by Application (2017-2028)
  • Figure 27. Europe Cytotoxic Drug Market Size Share by Country (2017-2028)
  • Figure 28. Germany Cytotoxic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. France Cytotoxic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. U.K. Cytotoxic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. Italy Cytotoxic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. Russia Cytotoxic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 33. Nordic Countries Cytotoxic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 34. Asia-Pacific Cytotoxic Drug Market Size YoY (2017-2028) & (US$ Million)
  • Figure 35. Asia Pacific Cytotoxic Drug Market Size Market Share by Type (2017-2028)
  • Figure 36. Asia Pacific Cytotoxic Drug Market Size Market Share by Application (2017-2028)
  • Figure 37. Asia Pacific Cytotoxic Drug Market Size Share by Region (2017-2028)
  • Figure 38. China Cytotoxic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. Japan Cytotoxic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. South Korea Cytotoxic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 41. Southeast Asia Cytotoxic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 42. India Cytotoxic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 43. Australia Cytotoxic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 44. Latin America Cytotoxic Drug Market Size YoY (2017-2028) & (US$ Million)
  • Figure 45. Latin America Cytotoxic Drug Market Size Market Share by Type (2017-2028)
  • Figure 46. Latin America Cytotoxic Drug Market Size Market Share by Application (2017-2028)
  • Figure 47. Latin America Cytotoxic Drug Market Size Share by Country (2017-2028)
  • Figure 48. Mexico Cytotoxic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 49. Brazil Cytotoxic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 50. Middle East & Africa Cytotoxic Drug Market Size YoY (2017-2028) & (US$ Million)
  • Figure 51. Middle East and Africa Cytotoxic Drug Market Size Market Share by Type (2017-2028)
  • Figure 52. Middle East and Africa Cytotoxic Drug Market Size Market Share by Application (2017-2028)
  • Figure 53. Middle East and Africa Cytotoxic Drug Market Size Share by Country (2017-2028)
  • Figure 54. Turkey Cytotoxic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 55. Saudi Arabia Cytotoxic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 56. UAE Cytotoxic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 57. Roche Revenue Growth Rate in Cytotoxic Drug Business (2017-2022)
  • Figure 58. Eli Lilly Revenue Growth Rate in Cytotoxic Drug Business (2017-2022)
  • Figure 59. Celgene Revenue Growth Rate in Cytotoxic Drug Business (2017-2022)
  • Figure 60. Sanofi Revenue Growth Rate in Cytotoxic Drug Business (2017-2022)
  • Figure 61. eisai Revenue Growth Rate in Cytotoxic Drug Business (2017-2022)
  • Figure 62. Sumitomo Dainippon Pharma Revenue Growth Rate in Cytotoxic Drug Business (2017-2022)
  • Figure 63. Merck Revenue Growth Rate in Cytotoxic Drug Business (2017-2022)
  • Figure 64. Seattle Genetics Revenue Growth Rate in Cytotoxic Drug Business (2017-2022)
  • Figure 65. Takeda Revenue Growth Rate in Cytotoxic Drug Business (2017-2022)
  • Figure 66. Haosoh Pharma Revenue Growth Rate in Cytotoxic Drug Business (2017-2022)
  • Figure 67. Novartis Revenue Growth Rate in Cytotoxic Drug Business (2017-2022)
  • Figure 68. AstraZeneca Revenue Growth Rate in Cytotoxic Drug Business (2017-2022)
  • Figure 69. Jazz Pharma Revenue Growth Rate in Cytotoxic Drug Business (2017-2022)
  • Figure 70. Spectrum Pharma Revenue Growth Rate in Cytotoxic Drug Business (2017-2022)
  • Figure 71. Bottom-up and Top-down Approaches for This Report
  • Figure 72. Data Triangulation
  • Figure 73. Key Executives Interviewed
目次

This research report focuses on the Cytotoxic Drug Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Cytotoxic Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Injection
    • 1.2.3 Solid Oral Dose Forms
    • 1.2.4 Others
  • 1.3 Market by Application
    • 1.3.1 Global Cytotoxic Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Breast Cancer
    • 1.3.3 Blood Cancer
    • 1.3.4 Prostate Cancer
    • 1.3.5 Respiratory/Lung Cancer
    • 1.3.6 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Cytotoxic Drug Market Perspective (2017-2028)
  • 2.2 Cytotoxic Drug Growth Trends by Region
    • 2.2.1 Cytotoxic Drug Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Cytotoxic Drug Historic Market Size by Region (2017-2022)
    • 2.2.3 Cytotoxic Drug Forecasted Market Size by Region (2023-2028)
  • 2.3 Cytotoxic Drug Market Dynamics
    • 2.3.1 Cytotoxic Drug Industry Trends
    • 2.3.2 Cytotoxic Drug Market Drivers
    • 2.3.3 Cytotoxic Drug Market Challenges
    • 2.3.4 Cytotoxic Drug Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Cytotoxic Drug Players by Revenue
    • 3.1.1 Global Top Cytotoxic Drug Players by Revenue (2017-2022)
    • 3.1.2 Global Cytotoxic Drug Revenue Market Share by Players (2017-2022)
  • 3.2 Global Cytotoxic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Cytotoxic Drug Revenue
  • 3.4 Global Cytotoxic Drug Market Concentration Ratio
    • 3.4.1 Global Cytotoxic Drug Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Cytotoxic Drug Revenue in 2021
  • 3.5 Cytotoxic Drug Key Players Head office and Area Served
  • 3.6 Key Players Cytotoxic Drug Product Solution and Service
  • 3.7 Date of Enter into Cytotoxic Drug Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Cytotoxic Drug Breakdown Data by Type

  • 4.1 Global Cytotoxic Drug Historic Market Size by Type (2017-2022)
  • 4.2 Global Cytotoxic Drug Forecasted Market Size by Type (2023-2028)

5 Cytotoxic Drug Breakdown Data by Application

  • 5.1 Global Cytotoxic Drug Historic Market Size by Application (2017-2022)
  • 5.2 Global Cytotoxic Drug Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Cytotoxic Drug Market Size (2017-2028)
  • 6.2 North America Cytotoxic Drug Market Size by Type
    • 6.2.1 North America Cytotoxic Drug Market Size by Type (2017-2022)
    • 6.2.2 North America Cytotoxic Drug Market Size by Type (2023-2028)
    • 6.2.3 North America Cytotoxic Drug Market Share by Type (2017-2028)
  • 6.3 North America Cytotoxic Drug Market Size by Application
    • 6.3.1 North America Cytotoxic Drug Market Size by Application (2017-2022)
    • 6.3.2 North America Cytotoxic Drug Market Size by Application (2023-2028)
    • 6.3.3 North America Cytotoxic Drug Market Share by Application (2017-2028)
  • 6.4 North America Cytotoxic Drug Market Size by Country
    • 6.4.1 North America Cytotoxic Drug Market Size by Country (2017-2022)
    • 6.4.2 North America Cytotoxic Drug Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Cytotoxic Drug Market Size (2017-2028)
  • 7.2 Europe Cytotoxic Drug Market Size by Type
    • 7.2.1 Europe Cytotoxic Drug Market Size by Type (2017-2022)
    • 7.2.2 Europe Cytotoxic Drug Market Size by Type (2023-2028)
    • 7.2.3 Europe Cytotoxic Drug Market Share by Type (2017-2028)
  • 7.3 Europe Cytotoxic Drug Market Size by Application
    • 7.3.1 Europe Cytotoxic Drug Market Size by Application (2017-2022)
    • 7.3.2 Europe Cytotoxic Drug Market Size by Application (2023-2028)
    • 7.3.3 Europe Cytotoxic Drug Market Share by Application (2017-2028)
  • 7.4 Europe Cytotoxic Drug Market Size by Country
    • 7.4.1 Europe Cytotoxic Drug Market Size by Country (2017-2022)
    • 7.4.2 Europe Cytotoxic Drug Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Cytotoxic Drug Market Size (2017-2028)
  • 8.2 Asia-Pacific Cytotoxic Drug Market Size by Type
    • 8.2.1 Asia-Pacific Cytotoxic Drug Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Cytotoxic Drug Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Cytotoxic Drug Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Cytotoxic Drug Market Size by Application
    • 8.3.1 Asia-Pacific Cytotoxic Drug Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Cytotoxic Drug Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Cytotoxic Drug Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Cytotoxic Drug Market Size by Region
    • 8.4.1 Asia-Pacific Cytotoxic Drug Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Cytotoxic Drug Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Cytotoxic Drug Market Size (2017-2028)
  • 9.2 Latin America Cytotoxic Drug Market Size by Type
    • 9.2.1 Latin America Cytotoxic Drug Market Size by Type (2017-2022)
    • 9.2.2 Latin America Cytotoxic Drug Market Size by Type (2023-2028)
    • 9.2.3 Latin America Cytotoxic Drug Market Share by Type (2017-2028)
  • 9.3 Latin America Cytotoxic Drug Market Size by Application
    • 9.3.1 Latin America Cytotoxic Drug Market Size by Application (2017-2022)
    • 9.3.2 Latin America Cytotoxic Drug Market Size by Application (2023-2028)
    • 9.3.3 Latin America Cytotoxic Drug Market Share by Application (2017-2028)
  • 9.4 Latin America Cytotoxic Drug Market Size by Country
    • 9.4.1 Latin America Cytotoxic Drug Market Size by Country (2017-2022)
    • 9.4.2 Latin America Cytotoxic Drug Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Cytotoxic Drug Market Size (2017-2028)
  • 10.2 Middle East & Africa Cytotoxic Drug Market Size by Type
    • 10.2.1 Middle East & Africa Cytotoxic Drug Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Cytotoxic Drug Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Cytotoxic Drug Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Cytotoxic Drug Market Size by Application
    • 10.3.1 Middle East & Africa Cytotoxic Drug Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Cytotoxic Drug Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Cytotoxic Drug Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Cytotoxic Drug Market Size by Country
    • 10.4.1 Middle East & Africa Cytotoxic Drug Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Cytotoxic Drug Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Roche
    • 11.1.1 Roche Company Details
    • 11.1.2 Roche Business Overview
    • 11.1.3 Roche Cytotoxic Drug Introduction
    • 11.1.4 Roche Revenue in Cytotoxic Drug Business (2017-2022)
    • 11.1.5 Roche Recent Developments
  • 11.2 Eli Lilly
    • 11.2.1 Eli Lilly Company Details
    • 11.2.2 Eli Lilly Business Overview
    • 11.2.3 Eli Lilly Cytotoxic Drug Introduction
    • 11.2.4 Eli Lilly Revenue in Cytotoxic Drug Business (2017-2022)
    • 11.2.5 Eli Lilly Recent Developments
  • 11.3 Celgene
    • 11.3.1 Celgene Company Details
    • 11.3.2 Celgene Business Overview
    • 11.3.3 Celgene Cytotoxic Drug Introduction
    • 11.3.4 Celgene Revenue in Cytotoxic Drug Business (2017-2022)
    • 11.3.5 Celgene Recent Developments
  • 11.4 Sanofi
    • 11.4.1 Sanofi Company Details
    • 11.4.2 Sanofi Business Overview
    • 11.4.3 Sanofi Cytotoxic Drug Introduction
    • 11.4.4 Sanofi Revenue in Cytotoxic Drug Business (2017-2022)
    • 11.4.5 Sanofi Recent Developments
  • 11.5 eisai
    • 11.5.1 eisai Company Details
    • 11.5.2 eisai Business Overview
    • 11.5.3 eisai Cytotoxic Drug Introduction
    • 11.5.4 eisai Revenue in Cytotoxic Drug Business (2017-2022)
    • 11.5.5 eisai Recent Developments
  • 11.6 Sumitomo Dainippon Pharma
    • 11.6.1 Sumitomo Dainippon Pharma Company Details
    • 11.6.2 Sumitomo Dainippon Pharma Business Overview
    • 11.6.3 Sumitomo Dainippon Pharma Cytotoxic Drug Introduction
    • 11.6.4 Sumitomo Dainippon Pharma Revenue in Cytotoxic Drug Business (2017-2022)
    • 11.6.5 Sumitomo Dainippon Pharma Recent Developments
  • 11.7 Merck
    • 11.7.1 Merck Company Details
    • 11.7.2 Merck Business Overview
    • 11.7.3 Merck Cytotoxic Drug Introduction
    • 11.7.4 Merck Revenue in Cytotoxic Drug Business (2017-2022)
    • 11.7.5 Merck Recent Developments
  • 11.8 Seattle Genetics
    • 11.8.1 Seattle Genetics Company Details
    • 11.8.2 Seattle Genetics Business Overview
    • 11.8.3 Seattle Genetics Cytotoxic Drug Introduction
    • 11.8.4 Seattle Genetics Revenue in Cytotoxic Drug Business (2017-2022)
    • 11.8.5 Seattle Genetics Recent Developments
  • 11.9 Takeda
    • 11.9.1 Takeda Company Details
    • 11.9.2 Takeda Business Overview
    • 11.9.3 Takeda Cytotoxic Drug Introduction
    • 11.9.4 Takeda Revenue in Cytotoxic Drug Business (2017-2022)
    • 11.9.5 Takeda Recent Developments
  • 11.10 Haosoh Pharma
    • 11.10.1 Haosoh Pharma Company Details
    • 11.10.2 Haosoh Pharma Business Overview
    • 11.10.3 Haosoh Pharma Cytotoxic Drug Introduction
    • 11.10.4 Haosoh Pharma Revenue in Cytotoxic Drug Business (2017-2022)
    • 11.10.5 Haosoh Pharma Recent Developments
  • 11.11 Novartis
    • 11.11.1 Novartis Company Details
    • 11.11.2 Novartis Business Overview
    • 11.11.3 Novartis Cytotoxic Drug Introduction
    • 11.11.4 Novartis Revenue in Cytotoxic Drug Business (2017-2022)
    • 11.11.5 Novartis Recent Developments
  • 11.12 AstraZeneca
    • 11.12.1 AstraZeneca Company Details
    • 11.12.2 AstraZeneca Business Overview
    • 11.12.3 AstraZeneca Cytotoxic Drug Introduction
    • 11.12.4 AstraZeneca Revenue in Cytotoxic Drug Business (2017-2022)
    • 11.12.5 AstraZeneca Recent Developments
  • 11.13 Jazz Pharma
    • 11.13.1 Jazz Pharma Company Details
    • 11.13.2 Jazz Pharma Business Overview
    • 11.13.3 Jazz Pharma Cytotoxic Drug Introduction
    • 11.13.4 Jazz Pharma Revenue in Cytotoxic Drug Business (2017-2022)
    • 11.13.5 Jazz Pharma Recent Developments
  • 11.14 Spectrum Pharma
    • 11.14.1 Spectrum Pharma Company Details
    • 11.14.2 Spectrum Pharma Business Overview
    • 11.14.3 Spectrum Pharma Cytotoxic Drug Introduction
    • 11.14.4 Spectrum Pharma Revenue in Cytotoxic Drug Business (2017-2022)
    • 11.14.5 Spectrum Pharma Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer